{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:20:19Z","timestamp":1782937219717,"version":"3.54.5"},"reference-count":39,"publisher":"Baishideng Publishing Group Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJN"],"published-print":{"date-parts":[[2021,11,25]]},"DOI":"10.5527\/wjn.v10.i6.109","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T04:45:23Z","timestamp":1637642723000},"page":"109-121","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of recombinant human erythropoietin (Hema-Plus<sup>\u00ae<\/sup>) for management of anemia in Thai patients on peritoneal dialysis"],"prefix":"10.5527","volume":"10","author":[{"given":"Piyatida","family":"Chuengsaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surapong","family":"Narenpitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchai","family":"Sritippayawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.525"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.97"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.21.1.12"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2009.09.001"},{"key":"B5","doi-asserted-by":"crossref","unstructured":"Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 1990; 263: 825-830","DOI":"10.1001\/jama.263.6.825"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000182958"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1032"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.12.021"},{"key":"B9","unstructured":"Taylor and Francis Group.   Hema-Plus 2000 IU, 4000 IU, 10000 IU Package Insert 2011. [cited 10 April 2021]. Available from: https:\/\/www.taylorfrancis.com\/chapters\/mono\/10.1201\/9781482295467-17\/iu-iu-andrew-peacock"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2007.00810.x"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.03.010"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.06.008"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2013.02.011"},{"key":"B16","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons S, Amin N, Carter WB, Kamberg C.   Kidney Disease Quality of Life Short Form (KDQOL-SF \u2122), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: RAND Corporation; 1997"},{"key":"B17","unstructured":"Thanakitcharu P, Siriwiwatanakul N. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia. J Med Assoc Thai 2007; 90: 2574-2586"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.04.014"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V571517"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.35"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-12-992"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-S3-19"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2005.18215.x"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.2.353"},{"key":"B25","unstructured":"Liu H, Yao Y, Cao Y, Yang X, Huang B, Han X, Ren C. Anemia management trends in patients on peritoneal dialysis in the past 10 years. Int J Clin Exp Med 2015; 8: 18050-18057"},{"key":"B26","unstructured":"Singh PK.   Make medicines accessible for all. [cited 10 April 2021]. Available from: https:\/\/www.who.int\/southeastasia\/news\/opinion-editorials\/detail\/make-medicines-accessible-for-all 2017"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2006.00141.x"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5414\/cnp60335"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000143815.15433.87"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.323"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00659.x"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V113539"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg070"},{"key":"B34","unstructured":"Goicoechea M, Gomez-Campdera F, Polo JR, Tejedor A, Ruiz MA, Vazquez I, Verde E, Valderrabano F. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy. Clin Nephrol 1996; 45: 420-421"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.5.1206"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118484"},{"key":"B37","doi-asserted-by":"crossref","unstructured":"Strengers PFW, Twuijver Ev.   Chapter 33-Blood, blood components, plasma, and plasma products. In: Aronson JK, editor. Side Effects of Drugs Annual: Elsevier; 2009: 527-546","DOI":"10.1016\/S0378-6080(09)03133-X"},{"key":"B38","doi-asserted-by":"crossref","unstructured":"Nomoto Y, Kawaguchi Y, Kubota M, Tagawa H, Kubo K, Ogura Y, Shoji T, Kawada Y, Koshikawa S, Mimura N. A multicenter study with once a week or once every two weeks high-dose subcutaneous administration of recombinant human erythropoietin in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 56-60","DOI":"10.1177\/089686089401400111"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01749.x"}],"container-title":["World Journal of Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-6124\/full\/v10\/i6\/109.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T04:45:29Z","timestamp":1637642729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-6124\/full\/v10\/i6\/109.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":39,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5527\/wjn.v10.i6.109","relation":{},"ISSN":["2220-6124"],"issn-type":[{"value":"2220-6124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}